Equities

Pediatrix Medical Group Inc

Pediatrix Medical Group Inc

Actions
  • Price (EUR)14.30
  • Today's Change-0.20 / -1.38%
  • Shares traded0.00
  • 1 Year change+62.50%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments178103487
Total Receivables, Net280297316
Total Inventory------
Prepaid expenses141519
Other current assets, total121319
Total current assets483428841
Property, plant & equipment, net146140136
Goodwill, net1,3841,5321,505
Intangibles, net211822
Long term investments------
Note receivable - long term------
Other long term assets82123131
Total assets2,2202,3482,723
LIABILITIES
Accounts payable353237
Accrued expenses337364377
Notes payable/short-term debt000
Current portion long-term debt/capital leases15152.49
Other current liabilities, total2.161611
Total current liabilities389427427
Total long term debt6186361,002
Total debt6336511,005
Deferred income tax343441
Minority interest--00.21
Other liabilities, total329359355
Total liabilities1,3711,4561,826
SHAREHOLDERS EQUITY
Common stock0.840.830.86
Additional paid-in capital1,0009841,050
Retained earnings (accumulated deficit)(149)(89)(155)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(2.21)(3.74)1.32
Total equity849892896
Total liabilities & shareholders' equity2,2202,3482,723
Total common shares outstanding848386
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.